Gentian Diagnostics ASA — Director's Dealing 2020

Aug 27, 2020

Primary insider notification - Korr

Primary insider notification - Korr

Moss 27.08.20

Vingulmork Predictor AS, a company controlled by Erling Sundrehagen, Chief Scientific Officer in Gentian Diagnostics AS (“Gentian”), has today* sold 40,000 shares at NOK 74 per share raising gross proceeds of NOK 2.96 million. The proceeds will be used to settle tax obligations from a real estate transaction in Sweden. After the Transaction, Erling Sundrehagen and associated companies own 184,083 shares and 50,000 options in Gentian. Erling Sundrehagen and associated companies have entered into a lock-up agreement for 6 months for the remaining shares they hold in Gentian.

The transaction was done as a block trade towards a large Norwegian institutional investor

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

* The date for the transaction was not included in the original notification.

For further information, please contact:

Njaal Kind

CFO, Gentian Diagnostics AS

E-mail: njaal.kind@gentian.no

Cell Phone: +47 919 06 525